Hermann Kreyenberg
Overview
Explore the profile of Hermann Kreyenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
981
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moser L, Heim C, Koschade S, Wendel P, Bozkurt S, Harenkamp S, et al.
Front Immunol
. 2025 Feb;
16:1485817.
PMID: 39963129
Introduction: CAR-T cell therapy, though successful in hematologic malignancies, faces challenges in solid tumors due to limitations of autologous T cells. Cytokine-induced killer (CIK) cells can be given safely across...
2.
Fekadu-Siebald J, Fuchs N, Zahn S, Rommel M, Schenk F, Huenecke S, et al.
Stem Cell Res
. 2024 Nov;
81:103598.
PMID: 39522300
Leukocyte Adhesion Deficiency Type I (LAD I) is a rare inborn error of immunity caused by mutations in the ITGB2 gene coding for β2-integrin CD18 on the surface of leukocytes....
3.
Kuci Z, Piede N, Vogelsang K, Pfeffermann L, Wehner S, Salzmann-Manrique E, et al.
J Transl Med
. 2024 Jan;
22(1):39.
PMID: 38195462
Background: According to the definition of the International Society for Cell and Gene Therapy (ISCT), mesenchymal stromal cells (MSCs) do not express HLA-DR. This phenotypic marker as a release criterion...
4.
Luib L, Kreyenberg H, Michaelis S, Handgretinger R, Mezger M
Pediatr Transplant
. 2023 Feb;
27(4):e14483.
PMID: 36750990
Background: Since the measurement of measurable residual disease (MRD) is part of clinical routine examination for children affected with acute lymphoblastic leukemia (ALL), continuous efforts are made to improve its...
5.
Albinger N, Pfeifer R, Nitsche M, Mertlitz S, Campe J, Stein K, et al.
Blood Cancer J
. 2022 Apr;
12(4):61.
PMID: 35418180
Acute myeloid leukemia (AML) is a malignant disorder derived from neoplastic myeloid progenitor cells characterized by abnormal proliferation and differentiation. Although novel therapeutics have recently been introduced, AML remains a...
6.
Peinelt A, Bremm M, Kreyenberg H, Cappel C, Banisharif-Dehkordi J, Erben S, et al.
Front Immunol
. 2022 Mar;
13:830773.
PMID: 35309367
Chimeric antigen receptor (CAR) T cell therapy is a potent new treatment option for relapsed or refractory hematologic malignancies. As the monitoring of CAR T cell kinetics can provide insights...
7.
Duecker R, de Mir Messa I, Jerkic S, Kochems A, Gottwald G, Moreno-Galdo A, et al.
Clin Transl Immunology
. 2022 Mar;
11(2):e1376.
PMID: 35228871
Objectives: Post-infectious bronchiolitis obliterans (PiBO) is a rare, chronic disease initiated by severe infection and followed by perpetuating inflammation and obliteration of the small airways. MicroRNAs (miRNAs) have been proposed...
8.
Duecker R, Adam E, Wirtz S, Gronau L, Khodamoradi Y, Eberhardt F, et al.
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34638691
A high incidence of thromboembolic events associated with high mortality has been reported in severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infections with respiratory failure. The present study characterized...
9.
Zielen S, Duecker R, Woelke S, Donath H, Bakhtiar S, Buecker A, et al.
J Clin Immunol
. 2021 Sep;
41(8):1878-1892.
PMID: 34477998
Patients with ataxia-telangiectasia (A-T) suffer from progressive cerebellar ataxia, immunodeficiency, respiratory failure, and cancer susceptibility. From a clinical point of view, A-T patients with IgA deficiency show more symptoms and...
10.
Queudeville M, Schlegel P, Heinz A, Lenz T, Doring M, Holzer U, et al.
Eur J Haematol
. 2020 Dec;
106(4):473-483.
PMID: 33320384
Objective: Pediatric patients with relapsed or refractory acute lymphoblastic leukemia have a poor prognosis. We here assess the response rates, adverse events, and long-term follow-up of pediatric patients with relapsed/refractory...